Targeting of BAFF and APRIL for autoimmunity and oncology

MC Ryan, IS Grewal - Therapeutic Targets of the TNF Superfamily, 2009 - Springer
BLyS and APRIL are tumor necrosis factor superfamily members shown to be important for B-
cell development, maturation and survival. Recent data also indicate that these cytokines …

Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor

D Seshasayee, P Valdez, M Yan, VM Dixit, D Tumas… - Immunity, 2003 - cell.com
BLyS, a key cytokine that sustains B cell maturation and tolerance, binds three receptors:
BR3, BCMA, and TACI. Results from knockout mice implicate a major functional role for BR3 …

BAFF inhibition: a new class of drugs for the treatment of autoimmunity

Z Liu, A Davidson - Experimental cell research, 2011 - Elsevier
BAFF (BLyS) and APRIL are TNF-like cytokines that support survival and differentiation of B
cells. Recent studies have discovered a role for BAFF in augmenting both innate and …

Povetacicept, an enhanced dual APRIL/BAFF antagonist that modulates B lymphocytes and pathogenic autoantibodies for the treatment of lupus and other B cell …

LS Evans, KE Lewis, D DeMonte… - Arthritis & …, 2023 - Wiley Online Library
Objective Dysregulated APRIL/BAFF signaling is implicated in the pathogenesis of multiple
autoimmune diseases, including systemic lupus erythematosus and lupus nephritis. We …

BAFF-and APRIL-targeted therapy in systemic autoimmune diseases

S Nakayamada, Y Tanaka - Inflammation and regeneration, 2016 - Springer
B cells play a pivotal role in autoimmunity not only by producing pathogenic autoantibodies
but also by modulating immune responses via the production of cytokines and chemokines …

[引用][C] A role for BLyS in tissue inflammation?

RH Carter - Arthritis & Rheumatism: Official Journal of the …, 2003 - Wiley Online Library
The story of B lymphocyte stimulator (BLyS [trademark of Human Genome Sciences,
Rockville, MD], BAFF, and others) is one of the most remarkable in recent biology. Less than …

Belimumab–an anti-BLyS human monoclonal antibody for rheumatoid arthritis

X Jin, C Ding - Expert Opinion on Biological Therapy, 2013 - Taylor & Francis
Introduction: B lymphocyte stimulator (BLyS) is a major regulatory factor that controls the
development and survival of B cells. Elevated serum levels of BLyS have been associated …

B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection

M Fabris, L Quartuccio, S Sacco, G De Marchi… - …, 2007 - academic.oup.com
Objectives. To investigate the role of B-Lymphocyte stimulator (BLyS) in mixed
cryoglobulinaemia syndrome (MCsn), a systemic vasculitis associated with a high risk to …

Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation

R Goenka, AH Matthews, B Zhang, PJ O'Neill… - Journal of Experimental …, 2014 - rupress.org
We have assessed the role of B lymphocyte stimulator (BLyS) and its receptors in the
germinal center (GC) reaction and affinity maturation. Despite ample BLyS retention on B …

B-cell-targeted therapies in systemic lupus erythematosus

VSF Chan, HHL Tsang, RCY Tam, L Lu… - Cellular & molecular …, 2013 - nature.com
Autoreactive B cells are one of the key immune cells that have been implicated in the
pathogenesis of systemic lupus erythematosus (SLE). In addition to the production of …